CompletedNot Applicable

Observation of Patients With Transfusional Hemosiderosis Treatment With Deferasirox

Egypt, Jordan, Spain120 participantsStarted 2011-07

Plain-language summary

This study will observe patients with transfusional hemosiderosis treated with deferasirox in actual practice setting.

Age range2 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓Patients treated with deferasirox for transfusional hemosiderosis according to the local prescribing information.

Serum Creatinine and liver enzyme levels

Timeframe: 3 years

Adverse Drug Reactions

Timeframe: 3 years

NCT IDNCT01394029

SponsorNovartis Pharmaceuticals

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2015-10